XOMA to Present At Two Investor Conferences in February
February 09, 2007 12:19 ET
|
XOMA Corporation
BERKELEY, Calif., Feb. 9, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today that J. David Boyle II, XOMA's vice president of finance and chief financial officer, will present an...
XOMA and Schering-Plough Add New Programs to Antibody Collaboration
January 17, 2007 08:50 ET
|
XOMA Corporation
BERKELEY, Calif., Jan. 17, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced that Schering-Plough Corporation (NYSE:SGP) exercised its right to initiate additional discovery and development...
XOMA Initiates Clinical Trial of NEUPREX At Harvard Medical School in Allogeneic Hematopoietic Stem Cell Transplantation
January 09, 2007 09:00 ET
|
XOMA Corporation
BERKELEY, Calif., Jan. 9, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today that it has initiated an open label, dose escalating Phase I/II clinical trial of NEUPREX(r) (opebacan) in...
XOMA Announces Pre-Clinical and Clinical Progress On HCD122
December 11, 2006 10:40 ET
|
XOMA Corporation
ORLANDO, Fla., Dec. 11, 2006 (PRIME NEWSWIRE) -- At the annual meeting of the American Society of Hematology (ASH), XOMA Ltd. (Nasdaq:XOMA), along with Novartis, announced pre-clinical and preliminary...
XOMA to Present At Piper Jaffray's 18th Annual Health Care Conference On December 1, 2006
November 29, 2006 14:21 ET
|
XOMA Corporation
BERKELEY, Calif., Nov. 29, 2006 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today that Paul Goodson, XOMA's Sr. Director, Investor Relations and Robert H. Gundel, XOMA's Vice President of...
XOMA Reports Third Quarter 2006 Results
November 09, 2006 16:04 ET
|
XOMA Corporation
BERKELEY, Calif., Nov. 9, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics for cancer and immunological disorders, today announced its...
XOMA Receives European Certification to Manufacture Investigational Medicinal Products
November 06, 2006 03:10 ET
|
XOMA Corporation
BERKELEY, Calif., Nov. 6, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA) today announced that its cGMP pharmaceutical manufacturing facilities have received Investigational Medicinal Products...
XOMA and Takeda Establish Collaboration for Therapeutic Antibody Discovery and Development
November 02, 2006 03:05 ET
|
XOMA Corporation
BERKELEY, Calif. and OSAKA, Japan, Nov. 2, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA) and Takeda Pharmaceutical Company Limited (TSE4502:Takeda) today announced that they have entered into an...
XOMA Announces November 9 Conference Call and Webcast Discussion of Third Quarter 2006 Results
November 01, 2006 14:00 ET
|
XOMA Corporation
BERKELEY, Calif., Nov. 1, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA) will issue a news release announcing its third-quarter financial results for the quarter ended September 30, 2006, on Thursday,...
XOMA to Humanize Attenuon's Novel Anti-Cancer Antibody
October 03, 2006 09:00 ET
|
XOMA Corporation
BERKELEY, Calif. and SAN DIEGO, Oct. 3, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA) and Attenuon, LLC today announced an agreement for XOMA to utilize its Human Engineering(tm) (HE(tm)) technology to...